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Introduction: Peripheral arterial disease (PAD) and
intermittent claudication (IC) decrease an individual’s
capacity to engage in physical activity (PA) with
potentially negative effects on PA behaviour. Strategies
to improve PA among this population may provide a
range of positive health benefits. We present a protocol
to assess the components of patient education
interventions that improve PA capacity and PA
behaviour in patients with PAD and IC.
Methods and analysis: Published peer-reviewed
studies will be searched in the following databases:
CINAHL, the Cochrane Library, OVID, ProQuest, AMED,
MEDLINE, PsycINFO, Web of Science Core Collection
and PEDro, to identify literature investigating the effect
of patient education on PA of patients with PAD and
IC, or studies that investigated patients’ perceptions or
experience with these interventions. Two authors will
independently perform screening for study eligibility,
result synthesis and then appraise study quality. For
interventions without follow-up, primary outcome
measures will include change in PA capacity, or
change in free-living PA behaviour; where there was a
follow-up postintervention, the primary outcome will be
rate of adherence to PA behaviour improvement.
A three-phase sequential explanatory synthesis of
mixed studies will be employed to answer the research
questions. Homogenous quantitative data will be
analysed using a random-effects model of meta-analysis
with results presented as relative risk for dichotomous
outcomes and as weighted or standardised means for
continuous outcomes. Qualitative data will be analysed
using thematic synthesis. This review protocol is
reported according to the Preferred Reporting Items for
Systematic review and Meta-Analysis Protocols
(PRISMA-P) 2015 guidelines.
Trial registration number: CRD42015027314.
INTRODUCTION
Peripheral arterial disease (PAD) is a
common, chronic, vascular condition
affecting more than a quarter of a billion
people in the world.1 Between 2000 and
2010, in developed countries, there was a
13% rise in the prevalence of this debilitat-
ing condition.1 The primary symptom asso-
ciated with PAD is intermittent claudication
(IC),2 which is described as lower limb pain
or discomfort that is induced by walking and
relieved by rest.3 4 Owing to the pain asso-
ciated with walking, patients with IC suffer
mobility impairment and loss of control,5
which have a negative impact on physical
and social functions.6 The eventual outcomes
of this are major limitations in the activities
of daily living,7 with decreasing quality of
life. In addition, the resultant decreased
ability to engage in physical activity (PA) and
the attendant deterioration in PA behaviour
may further compromise cardiovascular
health, potentially leading to an increased
risk of a future cardiovascular event8 in a vas-
cular system already compromised by PAD.9
Conservative treatments are usually the
recommended approach to managing
patients with IC.10 These include risk factor
modification, antiplatelet therapy and
walking exercise programmes. Despite the
fact that these interventions have shown
demonstrable effectiveness in terms of
improvement in PA capacity (walking ability)
when assessed in the laboratory,11–17 transla-
tion to free-living PA behaviour improvement
has rarely been demonstrated. Furthermore,
because PAD is a chronic condition requiring
long-term management, there is also the
potential for adverse effects of long-term use
of medication, most of which have only a
modest benefit.18 19 Additionally, a Cochrane
review reported that patients’ compliance
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with exercise instruction is a major challenge.20 Patients’
adherence is important because it may have an impact on
the effectiveness of an intervention. One common
approach to facilitating risk factor modification, particu-
larly in chronic, non-communicable disease management,
is patient education.21 Patient education has been
reported to improve PA behaviour among individuals with
stroke22 and chronic obstructive pulmonary disorders.23
There is not yet a consensus regarding the form of
interventions centred on patient education for improv-
ing PA capacity and behaviour of patients with IC. Two
previous reviews on home-based exercise programmes,24
and behaviour-change techniques25 for individuals with
IC have been conducted. Galea et al24 only included ran-
domised controlled trial (RCT) studies in their review.
In the context of complex, non-pharmacological inter-
ventions, such as patient education, this excludes poten-
tially relevant evidence derivable from other study
designs. In addition, both reviews24 25 were primarily
interested in PA capacity instead of free-living PA behav-
iour as the primary outcome and did not set out to con-
sider the qualitative experience or perspective of
patients to interventions aimed at improving PA among
this population. To develop a potentially effective educa-
tion intervention to improve free-living PA behaviour, a
clear understanding of the components required for
effectiveness and for optimum adherence of patients to
these interventions is needed. Similarly, the assessment
of how these interventions translate into free-living PA
behaviour should be considered. A systematic review of
the literature is warranted to explore the quantitative
and qualitative research evidence and to determine the
effective components of education interventions for
patients with PAD and IC. This article aims to report on
the protocol for a systematic mixed-studies review of the
topic and will be reported according to the Preferred
Reporting Items for Systematic review and Meta-Analysis
Protocols (PRISMA-P) 2015 guidelines.26 27
METHODS
Aim and review questions
The aim of this systematic mixed-studies review will be to
determine the effective components of patient educa-
tion for improving PA in individuals with IC through evi-
dence from the quantitative and qualitative research.
Specific objectives will include the following: (1) to
determine the effectiveness of patient education inter-
ventions in improving PA capacity and/or PA behaviour
in patients with IC and (2) to investigate experiences
and perceptions of patients with IC regarding patient
education interventions aimed at improving their PA
capacity and/or PA behaviour.
The proposed review will mainly seek to address the
question: ‘What constitutes the effective components of
education interventions for patients with IC based on
reports from published literature?’ To achieve the
research objectives above, two secondary research
questions to be answered are: ‘Are education interven-
tions effective in improving PA capacity and PA behaviour
in patients with IC?’ and ‘What are the patient experi-
ences and perceptions of education interventions aimed
at improving their PA capacity and/or PA behaviour?
Design
The protocol for this review has been registered with the
International Prospective Register of Systematic Reviews
(PROSPERO, CRD42015027314). A two-stage mixed-
studies review design approach will be employed. The
first stage will describe the studies meeting prior broad
eligibility criteria. Then, studies meeting a narrower set
of criteria will be pooled, potentially enabling a
meta-analysis in the second stage.
Eligibility criteria
Studies will be considered for eligibility according to the
following criteria.
Types of studies
Original research manuscripts in peer-reviewed journals
and conference proceedings will be included if pub-
lished in the English language. There will be no restric-
tions on the type of study design. Studies will be eligible
if one of the following was evaluated: the effect of educa-
tion interventions in patients with IC; the factors that
influence adherence to these interventions; the factors
that influence the effectiveness of the interventions; and
the experiences or perceptions of patients to education
interventions. RCTs and non-RCTs will be included in
the review, including quasi-RCTs, controlled clinical
trials, cross-over trials, controlled before and after trials
and non-controlled before and after studies.
Types of participants
Studies involving adult human participants aged
≥18 years will be eligible for inclusion. Studies involving
participants with symptomatic IC due to PAD will be
included. The basis for the diagnosis of IC may be
objective (eg, an ankle–brachial index (ABI) <0.9, evi-
dence of PAD on Doppler ultrasound or angiography),
or by questionnaire. If objective measures were not used
or reported, then studies reporting a clinical diagnosis
will be included. Only studies where all the participants
have a diagnosis of IC will be included. Studies with par-
ticipants with critical limb ischaemia will be excluded.
No particular restrictions will be considered regarding
the setting of studies to be included. Therefore, studies
conducted in health centres, clinics, hospitals or com-
munity settings will be included.
Types of interventions
Patient education interventions for patients with PAD
and IC will be considered for inclusion. Inclusion will
not be restricted to a particular form, dose, frequency,
intensity, duration of intervention or follow-up period
after intervention. For many studies, the intervention
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may be complex and may include exercise, medication,
nutrition, psychological interventions and social interven-
tions, in addition to the education component. Such
studies will be included as long as the effect of patient edu-
cation intervention can be determined. Specifically, search
terms will not be restricted to the term ‘education’. Studies
with other terminologies including, but not limited to,
home-based exercise, behavioural modification and self-
management interventions will be included in the review.
An intervention will be included if it is a structured educa-
tion aimed at PA behavioural modification. Interventions
consisting of simple instructions to ‘go home and exercise’
or advice to ‘change lifestyle’ will not be considered as a
patient education intervention. Studies with any type of
control group will be included, as well as studies with
pretest–post-test design with without a control.
Types of outcome measures
Studies which report changes in outcome measures of
free-living PA behaviour (eg, daily step counts, self-
report of improvement in PA behaviour), adherence to
these PA behaviour changes, change in PA capacity (eg,
pain-free walking distance, maximal walking distance,
walking time to onset of pain, maximum walking time)
or outcomes of patients’ experiences with interventions
will be included in the review. In addition, studies which
report on other clinical outcomes, such as pain, quality
of life (if measured with a generic valid instrument) and
psychological outcomes (eg, self-efficacy, confidence,
self-esteem, social functioning and coping) will be eli-
gible for inclusion. Studies will be included whether or
not an outcome of interest is reported as a primary or
secondary outcome in the original article, so long as a
distinct analysis was conducted for each outcome.
Studies will be included if they assess any of the out-
comes reporting PA capacity or free-living PA behaviour.
The basis of how PA capacity or free-living PA behaviour
was measured will not be used as a reason for exclusion.
All outcome variables will be collected as they are
reported in individual studies, and their original descrip-
tion in these individual studies will not be altered.
Clinical outcomes, or their close surrogate, reported by
individual studies will be analysed and graded.
Exclusion criteria
Studies without patient education interventions or
patients’ perception of these interventions will be
excluded from the review. Narrative review syntheses, sys-
tematic reviews, opinion papers, letters to the editor and
any study not including primary data or a clear method
of data analysis will also be excluded. Finally, duplicate
publications from the same study will be excluded. In
this case, the most comprehensive or most recent publi-
cation will be used.
Information sources and search strategy
A comprehensive and sensitive search strategy was
developed and piloted (see online supplementary
appendix 1). This strategy was developed in accordance
with the guidelines of the Cochrane Handbook for
Systematic Reviews,28 and the recommendations for
Health Care Review by the Centre for Reviews and
Dissemination.29 This search strategy will be performed
in two steps. The first step will be to identify studies in
bibliographic databases and search for grey literature.
The second step will be selection of studies for inclusion
based on prior eligibility criteria.
Studies will be identified using the previously devel-
oped search strategy (see online supplementary appen-
dix 1), to search the following databases: CINAHL, the
Cochrane Library, OVID, ProQuest, AMED, MEDLINE,
PsycINFO, Web of Science Core Collection and PEDro.
Trial registers and directory of open-access repository
websites including http://www.clinicaltrial.gov, http://
www.opendor.org and the Web of science conference
proceedings will also be searched. Additionally, searches
will be performed from the reference lists of identified
studies.
Study records and data management
Literature search results will be exported into RefWorks
to check for duplication of studies. Bibliographic
records will be exported from RefWorks into Microsoft
Excel (Microsoft. Microsoft Excel. Redmond,
Washington: Microsoft, 2010. Computer Software) to
facilitate the management and selection of articles for
inclusion. The review team will then develop, pilot and,
if required, refine eligibility questions and forms for the
studies included within the review.
Selection processes
Initial screening will be conducted simultaneously on
the title and abstract by one reviewer to identify poten-
tially relevant studies. A second review author will cross-
check these initial screening results. Two reviewers will
then read through the full text of selected studies for
further screening, again using the prior eligibility cri-
teria. Any difference of opinion occurring at any stage
regarding inclusion or exclusion will be resolved by dis-
cussion and reflection, in consultation with the third
reviewer if required. If a decision cannot be made based
on available information, study authors will be contacted
(to the maximum of three email attempts) to clarify
issues of selection of any study. If an author does not
respond, the study will be excluded and the reason for
exclusion recorded. Details of the flow of studies
throughout the process of assessment of eligibility and
study selection will be presented, along with the reasons
for exclusion at each stage of the process, in a flow chart
(PRISMA diagram).
Data collection processes
Quality appraisal for included studies
The Mixed Methods Appraisal Tool (MMAT)30 will be
employed to assess the quality of included studies. The
use of MMAT is to enable a valid, efficient and reliable
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assessment of the quality of the quantitative and qualita-
tive studies at the same time.30 31 Using this tool, the
studies will be assessed for the suitability of their study
design to the research objectives, risk of bias of included
studies, outcome measures, statistical issues, quality of
reporting, intervention quality and generalisability of the
study results.
Two reviewers will perform the data extraction inde-
pendently. Any disagreement regarding study eligibility
will be resolved by discussion and reflection, in consult-
ation with a third reviewer if required. The Data
Extraction Template developed by the Cochrane
Consumers and Communication Review Group32 will be
adapted to extract quantitative data from the quantita-
tive studies. The Supplementary Guidance for Inclusion
of Qualitative Research in Cochrane Systematic Reviews
of Interventions33 will be used to extract qualitative data
from the included studies.
Data items
Data will be collected from variables including authors’
reference, participants’ characteristics (including age
range, gender composition, inclusion and exclusion cri-
teria), study sample size (also the sample size of groups,
where available), criteria used in diagnosing IC, study
design, components of the intervention, context of the
intervention, who delivered the intervention, the dur-
ation of the intervention and follow-up (where avail-
able), attrition rate, outcome(s) assessed, the outcome
measurement methods/techniques, results, conclusions
and funding sources.
Outcomes and prioritisation
The main outcomes in the review will be PA behaviour
outcomes (daily step counts, time spent walking,
number of walking events, self-report of improvement in
PA behaviour), adherence to PA behaviour improvement
where there was a follow-up postintervention, and
patients’ experiences to intervention—responses to ques-
tion on patient perception of interventions.
For interventions without follow-up, the primary
outcome measures will be change in daily step counts
and self-reported change in PA behaviour. Where there
was a follow-up postintervention, adherence to changes
in these PA behaviour outcomes will also form the
primary analysis. Separate analysis will be conducted for
each outcome. Secondary outcomes will assess patients’
experiences with the intervention, patients’ perception
of interventions and PA capacity outcomes (eg, pain-free
walking distance, maximal walking distance, pain-free
walking time, maximal walking time). In addition, other
clinical outcomes such as pain and quality of life (if
measured with a generic valid instrument), and psycho-
logical outcomes (eg, self-efficacy, confidence, self-
esteem, social functioning and coping) will be assessed
as secondary outcomes.
Definitions used in the original included studies will
be used for all outcomes. Only data for the first period
of outcome assessment will be included for cross-over
studies in order to avoid a cross-over effect.
Risk of bias assessment in individual studies
Using the Cochrane Collaboration Tool for Risk of Bias
Assessment (Table 8.5a of the Cochrane Handbook for
Systematic Reviews of Interventions),28 risk of bias for
each of the intervention studies will be evaluated in six
key domains: (i) selection bias (random sequence gener-
ation, allocation concealment); (ii) performance bias
(blinding of personnel and participants); (iii) detection
bias (blinding of outcome assessments); (iv) bias due to
attrition (incomplete outcome data, including dropouts
and withdrawals); (v) reporting bias (selective reporting)
and (vi) other bias (other sources of bias not elsewhere
addressed). Assessment will be made in each of the
included studies, and they will be graded as ‘high risk’
or ‘low risk’ following a well-described procedure
(Table 8.5.d of the Cochrane Handbook for Systematic
Reviews of Interventions).28 Then, summary assessment
for each important outcome (across domains) within
and across studies will be conducted (Table 8.7.a of the
Cochrane Handbook for Systematic Reviews of
Interventions).28 When there is inadequate detail in a
study to make a judgement, the risk of bias in that study
will be reported as unclear. In such cases, the study
authors will be contacted to provide the required infor-
mation. Two reviewers will make judgements regarding
the risk of bias independent of each other. Areas of dif-
ferences will be resolved by discussion and reflection, or
in consultation with the third reviewer. Appraisal of the
quality of the included studies will only be carried out
after study selection has been completed, and during
data extraction and synthesis. After this, the strength of
evidence for this review will be reported.
RESULTS
This section of the protocol reports the planned data
analysis of the review.
Data synthesis including assessment of heterogeneity
A three-phase sequential explanatory synthesis of mixed
studies will be employed to answer the research ques-
tions.30 In the first phase, the question of the effective-
ness of patient education intervention will be answered.
In doing this, all quantitative study results which exam-
ined the effectiveness of these interventions will be pre-
sented, compared and pooled in an evidence table. The
effectiveness of patient education interventions will be
established by conducting a meta-analysis of the
effects.30 Data from quantitative studies that cannot be
analysed statistically will be interpreted using narrative
synthesis.
The second phase will seek to answer questions
regarding the attitude, experiences and perception of
patients to these interventions using information from
data from the study results. In doing this, qualitative
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thematic analysis will be used to integrate the results of
the qualitative studies and the qualitative results of
mixed-methods studies.30 Interpretation of the second
phase results will be used to establish the beneficial and
non-beneficial aspects of the interventions from the
patients’ point of view.
Finally, in the third phase, interpretation of the first
and second phases will be carried out to answer the
overall objective of the systematic review: ‘What are the
effective components of patient education interventions
for improving PA capacity and PA behaviour in patients
with IC?’ The effective components of the interventions
will be inferred by comparing the effectiveness of the
interventions that contained the useful components
identified from qualitative results with the interventions
that did not contain these components.
Characteristics of the retained studies sorted by year of
publication will be presented in a tabular form using
two different tables.31 One table will describe the quanti-
tative data from intervention studies, while the other will
describe qualitative studies. Both tables will have infor-
mation relating to authors’ references, study designs,
sample size, gender, age, study objectives, setting (rural
vs urban), data collection format, outcomes or
themes.32 33 In addition, the table for intervention
studies will contain information on scales used to assess
outcome, intervention objectives, components of the
intervention, component of the control, format and pro-
vider of the intervention, setting of the intervention
(home/community vs hospital), intervention and
follow-up periods, and results.34
Quantitative data analysis
Analysis and presentation of results will be made in hier-
archical order with the primary outcomes (relating to
PA behaviour change) coming before the additional out-
comes. It is anticipated that there may be significant het-
erogeneity in terms of clinical characteristics of
participants, diverse populations studied, different inter-
ventions provided, study designs, statistical strategy and
outcomes used. Hence, heterogeneity will be assessed
using Cochran’s χ2 test (at 10% α level) and further
quantified using I2 to decide which effect models to use
for meta-analysis.35 It is expected that there will be het-
erogeneity that cannot readily be dealt with.
Accordingly, studies with homogenous characteristics in
terms of design, intervention and comparator will be
pooled together for meta-analysis using a random-effects
model (9.5.4 Incorporating heterogeneity into
random-effects models).28 Other heterogeneous studies
will be interpreted using narrative synthesis following
the recommendation of the Centre for Reviews and
Dissemination to explore the relationship and findings
between and within the included studies.29
In conducting the meta-analysis, the statistical
approach will be to compare the absolute change in
means from the baseline (and the 95% CIs) following
intervention where baseline data are available, or to
compare change in the intervention group versus
control groups. Otherwise, the relative percentage
change between postintervention values in the interven-
tion and control groups will be compared. When an
outcome is assessed using dichotomous scales, the relative
risk (RR, and associated 95% CI) will be used to assess
treatment effects where possible. All continuous outcomes
will be assessed using the weighted mean difference or,
when different measurement scales are used, the standar-
dised mean difference. Skewed data and non-quantitative
data will be reported descriptively. All adverse effects
reported in the included studies will be recorded. Data
analysis will be completed using RevMan V.5.3 (Review
Manager (RevMan) [Computer program]. V. 5.3.
Copenhagen: The Nordic Cochrane Centre, The
Cochrane Collaboration, 2014).
Sensitivity analysis
Subgroup analysis will be limited to the primary
outcome (PA behaviour outcomes) and one secondary
outcome (PA capacity outcomes). Multiple subgroup
analyses will be conducted to ascertain the potential
influence of difference in intervention setting (hospital
vs home/community based), habitation setting (rural vs
urban habitation), design (RCTs vs non-RCTs) and inter-
vention type (structured education intervention vs
passive provision of information) in meta-analysis
outcome/effect size/treatment effect direction.
Publication bias
Data from studies published only as abstracts, where
available, will be combined to the review data to conduct
meta-analyses to see if such addition influences the
forest plot. The impact of publication bias will be investi-
gated using the funnel plot for asymmetry and Egger’s
regression test.35
Qualitative data analysis
A thematic synthesis method for qualitative research in
systematic reviews described by Thomas and Harden will
be used to synthesise the qualitative data.36 This method-
ology will follow somewhat overlapping three stages: (i)
free line-by-line coding of the findings of included
studies; (ii) organisation of these ‘free codes’ into related
areas to construct ‘descriptive’ themes and (iii) develop-
ment of ‘analytical’ themes from the interpretation and
abstraction of the descriptive themes into higher order
explanations. The review team will validate each of these
stages of qualitative analysis by comparing the generated
codes and themes with the results of the primary studies.
Confidence in cumulative evidence
The Grading of Recommendations Assessment,
Development and Evaluation (GRADE) approach will be
used to judge the quality of evidence of the studies to
determine the confidence in cumulative estimates in the
systematic review.37 Each study will be assessed across the
domains of risk of bias including consistency, directness,
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precision and publication bias. Adopting this approach,
a study will be rated as high where further research is
unlikely to change the effect estimates, moderate where
further research is likely to have an important impact on
the effect estimates or change the estimate, low where
further research is very likely to have an important
impact on the effect estimates and change the estimate,
or very low where the estimate of effects is extremely
uncertain.
How this review will be reported
This systematic review will be reported according to the
PRISMA statement, with all items relevant to the review
included. A PRISMA checklist applicable to this review
will be published with the final report.38
Dealing with protocol amendments during and after
review
In order to avoid the introduction of outcome reporting
bias, amendments will not be made on the quantitative
aspect of this review protocol based on the findings
from the included studies. This precaution is being
taken because publication bias easily affects quantitative
studies with the effect easy to identify. However, any justi-
fied unanticipated amendment, potentially arising from
a clearer understanding of the review questions, will be
documented and implemented. In the event of such
amendment, distinction will be made between the initial
review question(s) and any subsequent amendment(s)
in the report of the review.
Ethics and dissemination plans: This systematic review
will use data from published studies; therefore, ethical
approval is not required. This review is expected to
inform the development of patient education interven-
tions for improving free-living PA in individuals with IC.
Review findings will be published in a peer-review
journal. Results will also be presented at conferences
and, potentially, shared with relevant health authorities.
The review will be appropriately updated over time.
DISCUSSION
IC decreases an individual’s capacity to engage in PA,
potentially leading to deterioration in free-living PA
behaviour. Improvement in PA behaviour may be gained
through the use of patient education interventions. This
systematic review will provide evidence in support of, or
against, the hypothesis that interventions with a patient
education component can improve the free-living PA
behaviour of individuals with IC. This conclusion will be
derived from a synthesis of quantitative measurement of
PA behaviour outcomes following education interven-
tions and qualitative evidence regarding the effective-
ness and compliance with education interventions.
Overall, the review will clarify the existing evidence base
regarding the effect on PA of patient education interven-
tions, and allow the selection of effective components
for future tailored interventions.
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